|
US2021079074A1
|
|
Anti-ms4a4a antibodies and methods of use thereof
|
|
WO2020252066A1
|
|
Anti-sortilin antibodies for use in therapy
|
|
TW202016307A
|
|
Anti-cd33 antibodies and methods of use thereof
|
|
WO2020023920A1
|
|
Anti-siglec-5 antibodies and methods of use thereof
|
|
US2020024348A1
|
|
Anti-sortilin antibodies and methods of use thereof
|
|
SG11202010990TA
|
|
Anti-sirp-beta1 antibodies and methods of use thereof
|
|
EP3801767A1
|
|
Anti-siglec-7 antibodies and methods of use thereof
|
|
AU2019272885A1
|
|
Anti-SIRPA antibodies and methods of use thereof
|
|
EP3746484A1
|
|
Anti-ms4a6a antibodies and methods of use thereof
|
|
CN111971301A
|
|
anti-MS 4A4A antibodies and methods of use thereof
|
|
CN111886246A
|
|
anti-TMEM 106B antibodies and methods of use thereof
|
|
US2019174730A1
|
|
Transgenic mice expressing human trem proteins and methods of use thereof
|
|
EP3589658A1
|
|
Anti-cd33 antibodies and methods of use thereof
|
|
TW201912654A
|
|
anti-TREM2 antibody and method of use thereof
|
|
WO2018213316A1
|
|
Anti-siglec-5 antibodies and methods of use thereof
|
|
AU2017371070A1
|
|
Anti-SIRP-alpha antibodies and methods of use thereof
|
|
US2018160661A1
|
|
Siglec transgenic mice and methods of use thereof
|
|
US2018186878A1
|
|
Chimeric receptors and methods of use thereof
|
|
US2018186855A1
|
|
Chimeric receptors and methods of use thereof
|
|
US2020131264A1
|
|
Anti-TREM1 Antibodies and Methods of Use Thereof
|
